ContributorsPublishersAdvertisers

Identifying a key gene responsible for cancer drug resistance

MedicalXpress
 2021-10-12

Cover picture for the articleA researcher at the University of Missouri School of Medicine has discovered an enzyme that plays a key role in the ability of cancer cells to resist drug treatment. Immunomodulatory drugs like thalidomide, lenalidomide and pomalidomide have improved the treatment of patients with multiple myeloma and other blood cancers. But almost...

medicalxpress.com

Comments / 0

Comments / 0